Page last updated: 2024-10-24

buspirone and Parkinson Disease, Secondary

buspirone has been researched along with Parkinson Disease, Secondary in 1 studies

Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.

Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strouse, TB1
Salehmoghaddam, S1
Spar, JE1

Other Studies

1 other study available for buspirone and Parkinson Disease, Secondary

ArticleYear
Acute delirium and parkinsonism in a bupropion-treated liver transplant recipient.
    The Journal of clinical psychiatry, 1993, Volume: 54, Issue:12

    Topics: Buspirone; Delirium; Depressive Disorder; Dystonia; Humans; Liver Transplantation; Male; Middle Aged

1993